Publications
Select the category
H126: solid iSCIB1+ data underpins planned progress
FDA clears global Phase III trial for iSCIB1+
European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 10-12 December 2025 in London
Latest SCOPE data confirm durable improvement
Abundant development opportunities in immuno-oncology
AACR (American Association for Cancer Research) Annual Meeting, April 2025, Chicago, Illinois
No results found.
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.